Transfusion-associated bacterial sepsis.
نویسندگان
چکیده
منابع مشابه
Transfusion-Associated Bacterial Sepsis
Transfusion-associated bacterial sepsis (TABS) is caused by bacteria present in blood components. It is one of the earliest recognized adverse transfusion-associated reactions. Blood components most often become contaminated while blood is being collected from a donor; more seldom in the case of asymptomatic bacteremia or erroneous blood processing procedures (1). Although the risk for transfus...
متن کاملTwo cases of fatal transfusion-associated bacterial sepsis provoked by Providencia rettgeri.
used for thyroid disease could generate a chromosomal aberration, particularly (t 9,22) (q34 q11) developing, with a long latency, CML or in this case Ph+ ALL. Although the risk of leukemia after 131I exposure cannot be considered a contraindication to 131I therapy, strict hematologic follow-up of patients submitted to 131I treatment is recommended. Retrospective analysis of 131I exposure in la...
متن کاملTransfusion-transmitted Yersinia enterocolitica sepsis.
Bacterial sepsis has become the most frequent infectious complication of transfusion. Although Yersinia enterocolitica is a common enteropathogen usually causing relatively mild disease, it is nevertheless a prominent cause of life-threatening post-transfusion infection. To gain a better understanding of the clinical presentation and prognosis of this rare occurrence, we performed a systematic ...
متن کامل[Bacterial contamination on platelet concentrates: identification, antimicrobial susceptibility profile and transfusion-related sepsis].
INTRODUCTION Bacterial sepsis associated with the transfusion of platelet concentrates (PCs) results in serious clinical implications for patients. Given these implications, certain procedures have been integrated into the preparation and quality control of blood components to reduce the risk of bacterial contamination. This article describes the prevalence of bacterial contamination on transfu...
متن کاملTransfusion-related sepsis: a silent epidemic.
In this issue of Blood, Hong et al advocate for use of additional US Food and Drug Administration (FDA)–approved safety measures for transfusion. Most patients transfused with contaminated platelets do not show immediate clinical signs. Active surveillance suggests patient risk 10- to 40-fold higher than passive hemovigilance.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Microbiology Reviews
سال: 1994
ISSN: 0893-8512,1098-6618
DOI: 10.1128/cmr.7.3.290-302.1994